Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit

@inproceedings{Roux2017LocalAC,
  title={Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit},
  author={Alexandre Roux and Marc Zanello and Johan Pallud},
  booktitle={Journal of Neuro-Oncology},
  year={2017}
}
Grade IV glioma is the most common and aggressive primary brain tumour. Gross total resection with 5-aminolevulinic acid (5-ALA) guided surgery combined with local chemotherapy (carmustine wafers) is an attractive treatment strategy in these patients. No previous studies have examined the benefit carmustine wafers in a treatment programme of 5-ALA guided resection followed by a temozolomide-based chemoradiotherapy protocol. The objective of this study was to examine the benefit of carmustine… CONTINUE READING

5 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Grade IV glioma is the most common and aggressive primary brain tumour .
Grade IV glioma is the most common and aggressive primary brain tumour .
Grade IV glioma is the most common and aggressive primary brain tumour .
Grade IV glioma is the most common and aggressive primary brain tumour .
Grade IV glioma is the most common and aggressive primary brain tumour .
Grade IV glioma is the most common and aggressive primary brain tumour .
No previous studies have examined the benefit carmustine wafers in a treatment programme of 5-ALA guided resection followed by a temozolomide - based chemoradiotherapy protocol .
No previous studies have examined the benefit carmustine wafers in a treatment programme of 5-ALA guided resection followed by a temozolomide - based chemoradiotherapy protocol .
All Topics